These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 18304215

  • 1. Genetic variants of the cytochrome P450 and glutathione S-transferase associated with risk of bladder cancer in a south-eastern Chinese population.
    Shao J, Gu M, Zhang Z, Xu Z, Hu Q, Qian L.
    Int J Urol; 2008 Mar; 15(3):216-21. PubMed ID: 18304215
    [Abstract] [Full Text] [Related]

  • 2. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China.
    Tan W, Song N, Wang GQ, Liu Q, Tang HJ, Kadlubar FF, Lin DX.
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):551-6. PubMed ID: 10868687
    [Abstract] [Full Text] [Related]

  • 3. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.
    Li C, Wu W, Liu J, Qian L, Li A, Yang K, Wei Q, Zhou J, Zhang Z.
    Pharmacogenet Genomics; 2006 Apr; 16(4):245-51. PubMed ID: 16538171
    [Abstract] [Full Text] [Related]

  • 4. Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer.
    Srivastava DS, Mishra DK, Mandhani A, Mittal B, Kumar A, Mittal RD.
    Eur Urol; 2005 Aug; 48(2):339-44. PubMed ID: 16005379
    [Abstract] [Full Text] [Related]

  • 5. Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer.
    Kim EJ, Jeong P, Quan C, Kim J, Bae SC, Yoon SJ, Kang JW, Lee SC, Jun Wee J, Kim WJ.
    Urology; 2005 Jan; 65(1):70-5. PubMed ID: 15667866
    [Abstract] [Full Text] [Related]

  • 6. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer.
    Hung HC, Chuang J, Chien YC, Chern HD, Chiang CP, Kuo YS, Hildesheim A, Chen CJ.
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):901-5. PubMed ID: 9367063
    [Abstract] [Full Text] [Related]

  • 7. Interaction of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferase M1 to breast cancer in Taiwanese woman without smoking and drinking habits.
    Wu SH, Tsai SM, Hou MF, Lin HS, Hou LA, Ma H, Lin JT, Yeh FL, Tsai LY.
    Breast Cancer Res Treat; 2006 Nov; 100(1):93-8. PubMed ID: 16758119
    [Abstract] [Full Text] [Related]

  • 8. Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1.
    Lin DX, Tang YM, Peng Q, Lu SX, Ambrosone CB, Kadlubar FF.
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1013-8. PubMed ID: 9829710
    [Abstract] [Full Text] [Related]

  • 9. Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan.
    Wu MS, Chen CJ, Lin MT, Wang HP, Shun CT, Sheu JC, Lin JT.
    Int J Colorectal Dis; 2002 Sep; 17(5):338-43. PubMed ID: 12172927
    [Abstract] [Full Text] [Related]

  • 10. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer.
    Gattás GJ, de Carvalho MB, Siraque MS, Curioni OA, Kohler P, Eluf-Neto J, Wünsch-Filho V.
    Head Neck; 2006 Sep; 28(9):819-26. PubMed ID: 16721740
    [Abstract] [Full Text] [Related]

  • 11. Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study.
    Karagas MR, Park S, Warren A, Hamilton J, Nelson HH, Mott LA, Kelsey KT.
    Cancer Lett; 2005 Feb 28; 219(1):63-9. PubMed ID: 15694665
    [Abstract] [Full Text] [Related]

  • 12. Genetic variants of the XRCC7 gene involved in DNA repair and risk of human bladder cancer.
    Wang SY, Peng L, Li CP, Li AP, Zhou JW, Zhang ZD, Liu QZ.
    Int J Urol; 2008 Jun 28; 15(6):534-9. PubMed ID: 18422577
    [Abstract] [Full Text] [Related]

  • 13. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.
    Duarte EC, Ribeiro DC, Gomez MV, Ramos-Jorge ML, Gomez RS.
    Anticancer Res; 2008 Jun 28; 28(2A):1101-6. PubMed ID: 18507060
    [Abstract] [Full Text] [Related]

  • 14. Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India.
    Srivastava DS, Kumar A, Mittal B, Mittal RD.
    Arch Toxicol; 2004 Aug 28; 78(8):430-4. PubMed ID: 15057507
    [Abstract] [Full Text] [Related]

  • 15. Exon 3 polymorphisms and haplotypes of O6-methylguanine-DNA methyltransferase and risk of bladder cancer in southern China: a case-control analysis.
    Li C, Liu J, Li A, Qian L, Wang X, Wei Q, Zhou J, Zhang Z.
    Cancer Lett; 2005 Sep 08; 227(1):49-57. PubMed ID: 15885889
    [Abstract] [Full Text] [Related]

  • 16. Interactive effect of genetic polymorphism of glutathione S-transferase M1 and smoking on squamous cell lung cancer risk in Korea.
    Lee KM, Kang D, Lee SJ, Park SK, Lee KH, Choi JY, Kim SU, Choi H, Choi SH, Kim YW, Hong YC, Cho SH.
    Oncol Rep; 2006 Nov 08; 16(5):1035-9. PubMed ID: 17016589
    [Abstract] [Full Text] [Related]

  • 17. A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma.
    Wang YH, Yeh SD, Shen KH, Shen CH, Juang GD, Hsu LI, Chiou HY, Chen CJ.
    Toxicol Appl Pharmacol; 2009 Nov 15; 241(1):111-8. PubMed ID: 19686770
    [Abstract] [Full Text] [Related]

  • 18. The effect of CYP1A1 and GSTM1 gene polymorphisms in bladder cancer development in a Turkish population.
    Öztürk T, Kahraman ÖT, Toptaş B, Kisakesen Hİ, Çakalir C, Verim L, Öztürk O, İsbir T.
    In Vivo; 2011 Nov 15; 25(4):663-8. PubMed ID: 21709011
    [Abstract] [Full Text] [Related]

  • 19. Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India.
    Sobti RC, Al-Badran AI, Sharma S, Sharma SK, Krishan A, Mohan H.
    Cancer Genet Cytogenet; 2005 Jan 01; 156(1):68-73. PubMed ID: 15588859
    [Abstract] [Full Text] [Related]

  • 20. Cytochrome P450 2E1 and head and neck cancer: interaction with genetic and environmental risk factors.
    Ruwali M, Khan AJ, Shah PP, Singh AP, Pant MC, Parmar D.
    Environ Mol Mutagen; 2009 Jul 01; 50(6):473-82. PubMed ID: 19334053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.